Signet, the leading distributor of pharma excipients in India, is associated with 25 leading excipient manufacturers from the USA, Europe & Japan offering over 450 various excipients for almost every application and dosage form.
Launch of cooperation with BASF Pharma Solutions ZoomLab™
Essen, Germany. Evonik and BASF entered into an agreement, granting Evonik certain non-exclusive licensing rights to Opteinics™ - BASF’s digital solution to increase understanding and reduce the environmental footprint of the feed and animal protein industries. Evonik integrates the digital ready-to-use sustainability platform Opteinics™ into its global feed consultancy services. Combining Evonik’s innovative farm management tools and sustainability services with BASF's digital sustainability solution Opteinics™ will help customers to produce more sustainable feed and animal protein.
CHARLOTTESVILLE, Va., Sept. 14, 2021 /PRNewswire/ -- BrightSpec announced today the start of operation of a broadband Molecular Rotational Resonance spectrometer at BASF's research center in Ludwigshafen, Germany.
BASF has unveiled a company-wide reorganization in a bid to hike profits by $2.3 billion annually by 2021, the equivalent of increasing pretax profits by between 3% and 5% per year. The firm also aims to increase annual sales of products it claims make a substantial contribution to sustainability to $25 billion by 2025.
BASF AS completed a randomized, placebo-controlled clinical trial in the US, newly published in Nutrients, evaluating the use of high concentrate omega-3 to correct the nutritional deficiency of omega-3 fatty acid in patients with non-alcoholic fatty liver disease (NAFLD). Several studies have shown that NAFLD patients have lower levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Top EU court: GMO rules cover plant gene editing technique
Astrotech (NASDAQ: ASTC) today announced that it has filed a universal shelf registration statement on Form S-3 with the United States Securities and Exchange Commission, or the SEC. The registration statement is intended to provide the company with efficient access to the capital markets and increased financial flexibility.
There are several recent announcements of German companies opening laboratories in the U.S. It is probably not related to the recent news that the U.S. Justice Department gave Germany-based Bayer and U.S.-based Monsanto the go-ahead for their merger. Due to anti-trust issues, Monsanto has to sell about $9 billion in assets, and European regulators also required the sale of $2.54 billion in assets, which are being sold to BASF. The deal is expected to close by the end of June. After the various divestment, the combined agricultural supplies company will have sales of about 20 billion euros.
BASF has confirmed the innovation campus it is setting up in India will employ 300 people and cater for multiple markets across Asia and elsewhere.